Er. Sjoberg et al., EXPRESSION OF DE-N-ACETYL-GANGLIOSIDES IN HUMAN-MELANOMA CELLS IS INDUCED BY GENISTEIN OR NOCODAZOLE, The Journal of biological chemistry, 270(7), 1995, pp. 2921-2930
Neuraminic acid is the core structure of most known sialic acids. In n
atural systems, the amino group at the 5 position of neuraminic acid r
esidues is usually assumed to be acylated. Previously, synthetic de-N-
acetyl-gangliosides (with free amino groups at the 5 position of neura
minic acids) have been shown to modulate cellular proliferation and ty
rosine phosphokinase reactions. While indirect evidence has suggested
that traces of these molecules exist naturally in certain tumor cells,
further exploration has been hampered by the lack of a system showing
consistent expression at an easily detectable level. Using synthetic
compounds as antigens, we have developed highly specific monoclonal an
tibodies against de-N-acetyl-G(M3) and de-N-acetyl-G(D3) that require
both the free amino group and the exocyclic side chain of sialic acids
for recognition. Cultured human melanoma cells showed low but variabl
y detectable levels of reactivity with these antibodies. The ability o
f various biologically active molecules to stimulate this reactivity w
as explored. Of many compounds tested, only the tyrosine kinase inhibi
tor genistein induced reactivity in a dose dependent manner. Antibody
reactivity with ganglioside extracts from genistein-treated cells was
abolished by chemical re-N-acetylation and/or truncation of sialic aci
d side chains by mild periodate oxidation. High performance thin layer
chromatography immune-overlay analysis confirmed the presence of the
novel compound de-N-acetyl-G(D3) in these extracts. Several other tyro
sine kinase inhibitors tested did not give the same increase in de-N-a
cetyl-ganglioside expression. However, the microtubule inhibitor nocod
azole caused a similar accumulation of these molecules, particularly i
n non-adherent cells expected to be arrested at metaphase. Thus, genis
tein may induce de-N-acetyl-ganglioside expression by virtue of its kn
own ability to arrest cells in the G(2)M phase, rather than as a gener
al consequence of tyrosine kinase inhibition. These studies also provi
de a system in which to analyze the enzymatic basis of de-N-acetyl-gan
glioside expression and their potential roles as growth regulating mol
ecules.